Login/Sign Up
Bonspri Solution for Injection
Bonspri Solution for Injection is used to treat Chronic Lymphocytic Leukemia and Multiple sclerosis. It contains Ofatumumab, which works by inhibiting the B-cell lymphocytes that are responsible for the multiplication of cancer cells; this causes shrinkage of tumour cells and thereby prevents the growth and further spread of cancerous or non-cancerous cells. Bonspri Solution for Injection may cause certain side effects, such as nausea, vomiting, diarrhoea, fever, decreased platelet count, fatigue, cough, insomnia, injection site reactions and pain at the site of injection.
₹53846.94*
MRP ₹65667
18% off
₹55816.95*
MRP ₹65667
15% CB
₹9850.05 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Whats That
Bonspri Solution for Injection is an anti-cancer medicine used in the treatment of cancer. The intravenous route of this medicine is used in combination with chlorambucil for the treatment of CLL in patients for whom fludarabine-based therapy is considered inappropriate and as an extended treatment in patients who have a partial response after at least two lines of therapy. Chronic lymphocytic leukaemia is a cancer that occurs in the bone marrow and blood. The subcutaneous route of the medicine is used in treating relapsing forms of multiple sclerosis. It is a condition in which the immune system attacks the protective covering of the nerves called myelin.
Bonspri Solution for Injection contains Ofatumumab, which belongs to the class of monoclonal antibodies. It works by inhibiting the B-cell lymphocytes that are responsible for the multiplication of cancer cells.
Bonspri Solution for Injection may cause certain side effects, such as nausea, vomiting, diarrhoea, fever, decreased platelet count, fatigue, cough, insomnia, injection site reactions and pain at the site of injection. If the side effects bother you, inform your doctor. A trained healthcare professional will administer Bonspri Solution for Injection. Hence, do not self-administer.
While taking Bonspri Solution for Injection if you experience any allergic reaction, inform your doctor. Before receiving this injection, inform your doctor if you have any pre-existing or a history of liver/kidney disease, active infections, skin problems, or any allergic conditions. Bonspri Solution for Injection is known to cause fetal B-cell depletion in neonates. Hence, inform your physician if you are pregnant beforehand. Breastfeeding mothers should avoid taking Bonspri Solution for Injection.
Bonspri Solution for Injection contains Ofatumumab, which belongs to the class of CD20-directed cytolytic antibodies. It is used in the treatment of chronic lymphocytic leukaemia. This medicine works by binding to the CD20 antibody and causes lysis of B-cell lymphocytes responsible for the multiplication of cancer cells. This causes shrinkage of tumour cells and thereby prevents the growth and further spread of cancerous or non-cancerous cells.
For Chronic Lymphocytic leukemia:
For Multiple Sclerosis:
Bonspri Solution for Injection should be avoided if you are allergic to it or any other components present in it. Let your doctor know about your complete medical history, including current medication, to rule out any side effects/interactions. Before receiving this injection, inform your doctor if you have any history of liver/kidney disease, active infections, skin problems, or any allergic conditions. Bonspri Solution for Injection may cause remission of active infections, severe skin reactions, tumour lysis syndrome (tumour cells release their contents into the bloodstream), hepatitis B virus reactivation, progressive multifocal leukoencephalopathy, and hypersensitivity reactions in some patients. Hence, careful monitoring should be done during the entire treatment. Bonspri Solution for Injection may cause fetal B-cell depletion in infants. Hence, if you are pregnant or planning to become pregnant, inform your doctor beforehand. Before nursing, a breastfeeding mother should ask her oncologist whether this medicine is safe for use or not. Bonspri Solution for Injection is not recommended for use in children as the safety and efficacy are not established.
Drug-Drug Interactions: No interactions found.
Drug-Food Interactions: Avoid alcohol consumption and smoking.
Drug-Disease Interactions: Inform your doctor if you have kidney or liver disease, skin diseases, and infections before receiving Bonspri Solution for Injection.
Chronic Lymphocytic Leukaemia: It is a type of cancer that occurs in the bone marrow and blood. It increases the number of lymphocytes (a type of white blood cell). The symptoms include fever, enlarged liver, bone or joint pain, shortness of breath, weakness, and bleeding from gums or bruises.
Multiple sclerosis: Multiple sclerosis is a condition that affects the brain and spinal cord. The immune system attacks the protective covering of the nerves (myelin) and causes disrupted communication between the brain and body due to nerve damage. This causes symptoms such as problems with sensation, balance, vision, pain, impaired coordination, and fatigue.
Alcohol
Consult your doctor
It is unknown whether Bonspri Solution for Injection interacts with alcohol. Consult your doctor.
Pregnancy
Unsafe
Bonspri Solution for Injection is not recommended for use in pregnancy as it may cause fatal B-lymphocyte depletion in your foetus. Hence, if you are pregnant or planning pregnancy, inform your doctor before receiving Bonspri Solution for Injection.
Breast Feeding
Caution
If you are breastfeeding, inform your doctor before receiving Bonspri Solution for Injection. Your doctor may prescribe this medicine if the benefits outweigh the risks.
Driving
Caution
Bonspri Solution for Injection will be administered in the hospital setting. Hence, driving is not recommended.
Liver
Caution
If you have a pre-existing or a history of liver disease, inform your doctor before receiving Bonspri Solution for Injection. Bonspri Solution for Injection may cause increased bilirubin levels and liver failure. Hence, inform your doctor if you observe any symptoms such as fatigue, yellow discolouration of eyes, and dark coloured urine. A dose adjustment of this medicine or a suitable alternative may be advised based on your condition. A dose adjustment of this medicine or a suitable alternative may be advised based on your condition.
Kidney
Caution
If you have a pre-existing or a history of kidney disease, inform your doctor before receiving Bonspri Solution for Injection. A dose adjustment of this medicine or a suitable alternative may be advised based on your condition.
Children
Unsafe
Bonspri Solution for Injection is not recommended for use in children as the safety and efficacy are not established.
Country of origin